News
![Genentech signs deal with Parvus to tackle inflammatory diseases](/sites/default/files/styles/x_large/public/default_images/empty.jpg?itok=C-Mgnvzj)
Genentech signs deal with Parvus to tackle inflammatory dise...
Canada’s Parvus Therapeutics has signed a deal with Roche’s Genentech unit to develop, manufacture and market drugs for inflammatory bowel disease, autoimmune liver diseases, and coeliac di